PT3604303T - Novo derivado de pirrolopiridina, método para a produção do mesmo e utilizações do mesmo - Google Patents

Novo derivado de pirrolopiridina, método para a produção do mesmo e utilizações do mesmo

Info

Publication number
PT3604303T
PT3604303T PT179016803T PT17901680T PT3604303T PT 3604303 T PT3604303 T PT 3604303T PT 179016803 T PT179016803 T PT 179016803T PT 17901680 T PT17901680 T PT 17901680T PT 3604303 T PT3604303 T PT 3604303T
Authority
PT
Portugal
Prior art keywords
producing same
pyrrolopyridine derivative
novel pyrrolopyridine
novel
derivative
Prior art date
Application number
PT179016803T
Other languages
English (en)
Original Assignee
St Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Pharm Co Ltd filed Critical St Pharm Co Ltd
Publication of PT3604303T publication Critical patent/PT3604303T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT179016803T 2017-03-24 2017-03-24 Novo derivado de pirrolopiridina, método para a produção do mesmo e utilizações do mesmo PT3604303T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2017/003194 WO2018174320A1 (ko) 2017-03-24 2017-03-24 신규한 피롤로피리딘 유도체, 이의 제조방법 및 용도

Publications (1)

Publication Number Publication Date
PT3604303T true PT3604303T (pt) 2023-02-14

Family

ID=63584472

Family Applications (1)

Application Number Title Priority Date Filing Date
PT179016803T PT3604303T (pt) 2017-03-24 2017-03-24 Novo derivado de pirrolopiridina, método para a produção do mesmo e utilizações do mesmo

Country Status (17)

Country Link
US (1) US11214570B2 (pt)
EP (1) EP3604303B1 (pt)
JP (1) JP6781848B2 (pt)
KR (1) KR102148294B1 (pt)
CN (1) CN110461837B (pt)
AU (1) AU2017405244C9 (pt)
BR (1) BR112019019982A2 (pt)
CA (1) CA3057586C (pt)
DK (1) DK3604303T3 (pt)
ES (1) ES2938335T3 (pt)
HU (1) HUE061404T2 (pt)
MX (1) MX2019011220A (pt)
PL (1) PL3604303T3 (pt)
PT (1) PT3604303T (pt)
RU (1) RU2733723C1 (pt)
WO (1) WO2018174320A1 (pt)
ZA (1) ZA201906848B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3519409A1 (en) 2016-09-28 2019-08-07 Gilead Sciences, Inc. Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
KR20220023187A (ko) * 2020-08-20 2022-03-02 에스티팜 주식회사 피롤로피리딘 유도체 및 이들의 용도
CN117015542A (zh) * 2021-01-11 2023-11-07 St制药株式会社 吡咯并吡啶衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007534739A (ja) * 2004-04-26 2007-11-29 ファイザー・インク ピロロピリジン誘導体及びhivインテグラーゼ酵素阻害剤としてのその使用
EA019259B1 (ru) * 2007-11-16 2014-02-28 Джилид Сайенсиз, Инк. Ингибиторы репликации вируса иммунодефицита человека
AR076601A1 (es) 2009-05-21 2011-06-22 Chlorion Pharma Inc Pirimidinas como agentes terapeuticos
US8609653B2 (en) * 2011-07-15 2013-12-17 Glaxosmithkline Llc Azaindole compounds and methods for treating HIV
WO2013073875A1 (ko) 2011-11-15 2013-05-23 한국화학연구원 신규한 항바이러스성 피롤로피리딘 유도체 및 이의 제조방법
CA2876370A1 (en) * 2012-07-12 2014-01-16 Viiv Healthcare Uk Limited Compounds and methods for treating hiv
CN104704127A (zh) 2012-07-13 2015-06-10 莱雅公司 体外诊断受试者的薄皮状态的方法及相关应用
KR101592370B1 (ko) * 2014-06-09 2016-02-11 한국화학연구원 신규한 피롤로피리딘 유도체 및 이의 hiv 저해제로서의 용도

Also Published As

Publication number Publication date
WO2018174320A1 (ko) 2018-09-27
MX2019011220A (es) 2019-11-01
CA3057586A1 (en) 2018-09-27
BR112019019982A2 (pt) 2020-04-28
KR20190141152A (ko) 2019-12-23
PL3604303T3 (pl) 2023-04-11
CA3057586C (en) 2022-05-03
ZA201906848B (en) 2021-06-30
CN110461837A (zh) 2019-11-15
EP3604303A4 (en) 2020-10-07
DK3604303T3 (da) 2023-02-06
ES2938335T3 (es) 2023-04-10
AU2017405244C1 (en) 2021-02-11
HUE061404T2 (hu) 2023-06-28
US20200377498A1 (en) 2020-12-03
RU2733723C1 (ru) 2020-10-06
AU2017405244C9 (en) 2021-03-04
JP6781848B2 (ja) 2020-11-04
US11214570B2 (en) 2022-01-04
AU2017405244B9 (en) 2020-10-22
CN110461837B (zh) 2022-06-17
AU2017405244B2 (en) 2020-10-01
EP3604303B1 (en) 2023-01-18
AU2017405244A1 (en) 2019-11-07
KR102148294B1 (ko) 2020-08-26
EP3604303A1 (en) 2020-02-05
JP2020511482A (ja) 2020-04-16

Similar Documents

Publication Publication Date Title
HK1251977A1 (zh) 霧化單元的製造方法及霧化單元
HK1251551A1 (zh) 氮雜環丁烷衍生物、其製備方法及用途
HK1255566A1 (zh) 氧代吡啶酰胺類衍生物、其製備方法及其在醫藥上的應用
EP3632907C0 (en) N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF
EP3246327A4 (en) 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof
EP3594312A4 (en) COMPOSITION, PROCESS FOR ITS PRODUCTION AND ASSOCIATED USE
EP3309138A4 (en) Method for co-production of 2,3,3,3-tetrafluoropropylene and 1,3,3,3-tetrafluoropropylene
ZA201906079B (en) Novel ester compounds, method for the production thereof and use thereof
SG11202007554TA (en) Dioxazoline compound, preparation method therefor, and uses thereof
ZA201905065B (en) Novel ester compounds, method for the production thereof and use thereof
EP3575853A4 (en) METHOD FOR MANUFACTURING A STEREOSCOPIC IMAGE FORMING DEVICE, AND A STEREOSCOPIC IMAGE FORMING DEVICE
EP3636087A4 (en) METHOD OF MANUFACTURING A MATERIAL CONTAINING CLOTHING AND CORNICATED CLOTHING
ZA201906848B (en) Novel pyrrolopyridine derivative, method for producing same, and use thereof
EP3633713A4 (en) METHOD FOR MANUFACTURING A STRUCTURE AND STRUCTURE
EP3360863A4 (en) ETYIDATE DERIVATIVE AND INTERMEDIATE PRODUCT, MANUFACTURING METHOD AND USE THEREOF
EP3354648A4 (en) 4-SUBSTITUTED CUMARINE DERIVATIVE AND METHOD OF PREPARATION AND USE THEREOF
HK1244805A1 (zh) 一種新毒素及其中間體的製備方法
ZA202002138B (en) Method for preparing oxaspirocycle derivative, and intermediate thereof
IL250223B (en) A method for the preparation of the pyrimidine-1-ol compound, and its intermediates
SG11201709899QA (en) Microorganism producing o-acetyl-homoserine, and method for producing o-acetyl-homoserine by using same
EP3721886A4 (en) THERAPEUTIC PROCEDURE
EP3666751A4 (en) PROCESS FOR THE PREPARATION OF LATANOPROSTENE BUNOD AND INTERMEDIATE THEREOF
EP3395565A4 (en) Method for producing complex, and complex
GB2546498B (en) Novel crystalline form of picoxystrobin, method of preparing and use of the same
IL268584A (en) A 15-oxosteroid compound and its production method